Pfizer Inc. Closes Clinical Research Unit in Singapore

Published: Feb 08, 2013

The Republic's clinical research aspirations took a step back as Pfizer, the world's largest drugmaker, pulled the plug on its dedicated clinical research outfit at Raffles Hospital mid-way through its 10-year lease. Pfizer's exit from Singapore comes amid a shift in research and development models in the global biopharmaceutical industry, which has turned to more flexible and less costly partnerships, alliances and even crowdsourcing.

Back to news